CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,312,833 | -20.0% | 544,196 | 0.0% | 7.30% | -17.6% |
| Q1 2023 | $2,889,681 | -15.4% | 544,196 | 0.0% | 8.86% | -21.4% |
| Q4 2022 | $3,417,551 | -40.5% | 544,196 | 0.0% | 11.27% | -42.2% |
| Q3 2022 | $5,741,000 | +73.5% | 544,196 | -10.7% | 19.52% | +78.5% |
| Q2 2022 | $3,308,000 | -46.6% | 609,196 | -9.6% | 10.93% | +52.5% |
| Q1 2022 | $6,189,000 | -39.2% | 674,196 | 0.0% | 7.17% | +12.1% |
| Q4 2021 | $10,174,000 | -36.8% | 674,196 | 0.0% | 6.39% | -36.2% |
| Q3 2021 | $16,093,000 | – | 674,196 | – | 10.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 674,196 | $6,189,000 | 7.17% |
| 72 Investment Holdings, LLC | 474,067 | $4,352,000 | 4.76% |
| Velan Capital Investment Management LP | 210,695 | $1,934,000 | 1.80% |
| PFM Health Sciences, LP | 4,370,545 | $40,122,000 | 1.50% |
| Monashee Investment Management LLC | 470,000 | $4,315,000 | 1.25% |
| Avidity Partners Management LP | 2,819,067 | $25,879,000 | 0.54% |
| Rokos Capital Management LLP | 849,334 | $7,899,000 | 0.37% |
| Green Alpha Advisors, LLC | 49,674 | $456,000 | 0.31% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 181,304 | $1,664,000 | 0.25% |
| Tekla Capital Management LLC | 699,377 | $6,420,000 | 0.22% |